Clinical Trial

The Örebro Severe Traumatic Brain Injury Registry

Study acronym: ÖrSBID
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Traumatic brain injury and other severe brain injuries requiring neurointensive care are associated with high mortality, long-term disability and substantial societal burden. Despite advances in critical care, outcomes after severe brain injury remain difficult to predict and secondary brain injury plays a major role in determining prognosis. The Örebro Severe Brain Injury Database (ÖrSBID) is a prospective observational registry that aims to systematically collect detailed clinical, physiological, imaging and biological data from adult patients with severe brain injury requiring care at the neurointesive care unit or neurointermediate care unit at Örebro University Hospital. The purpose of the registry is to enable deep phenotyping of severe brain injury, improve understanding of secondary injury mechanisms, support outcome prediction and provide a platform for longitudinal follow-up and future research. No experimental interventions are performed as part of the study.
Trial Details
NCT Number NCT07398274
Lead Sponsor András Zoltán Buki
Conditions Severe Traumatic Brain Injury, Severe Brain Injury, Ischemic Stroke, Intracerebral Hemorrhage
Enrollment 200 participants
Start Date 2026-02-08
Primary Completion 2028-02-08 (estimated)
Study Completion 2028-02-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-09